A novel pyrrolo[3, 2‐d]pyrimidine derivative, as a vascular endothelial growth factor receptor and platelet‐derived growth factor receptor tyrosine kinase inhibitor, shows potent antitumor activity by suppression of tumor angiogenesis

Схожие документы

• Anti‐angiogenic and anti‐tumor effects of TAK‐593, a potent and selective inhibitor of vascular endothelial growth factor and platelet‐derived growth factor receptor tyrosine kinase
  по: Awazu, Yoshiko, et al.
  Опубликовано: (2013)
• Structure-Based Approach for the Discovery of Pyrrolo[3,2-d]pyrimidine-Based EGFR T790M/L858R Mutant Inhibitors
  по: Sogabe, Satoshi, et al.
  Опубликовано: (2012)
• 3-Aminopyrroles and their application in the synthesis of pyrrolo[3,2-d]pyrimidine (9-deazapurine) derivatives
  по: Abdellatif M. Salaheldin, et al.
  Опубликовано: (2008-10-01)
• Novel 5′-Norcarbocyclic Derivatives of Bicyclic Pyrrolo- and Furano[2,3-d]Pyrimidine Nucleosides
  по: Klimenko, Anna A., et al.
  Опубликовано: (2018)
• Synthesis, anticancer activity and docking studies of pyrazoline and pyrimidine derivatives as potential epidermal growth factor receptor (EGFR) inhibitors
  по: Menier Al-Anazi, et al.
  Опубликовано: (2022-07-01)